Atlas FDA

CONTIGEN BARD COLLAGEN IMPLANT

FDA premarket approval P900030/S005 · decided 1996-03-08

Approval details

PMA number
P900030
Supplement
S005
Supplement type
Normal 180 Day Track
Supplement reason
Labeling Change - Indications/instructions/shelf life/tradename
Trade name
CONTIGEN BARD COLLAGEN IMPLANT
Generic name
AGENT, BULKING, INJECTABLE FOR GASTRO-UROLOGY USE
Applicant
Allergan, Inc.
Date received
1995-11-01
Decision date
1996-03-08
Days to decision
128 days
Decision code
APPR
Product code
LNM
Advisory committee
Gastroenterology, Urology
Expedited review
No
Location
Goleta, CA
Statement
APPROVAL FOR:1) MARKETINGTHE CURRENT CONTIGEN IMPLANT PRODUCT LINE IN A MODIFIED PACKAGING CONFIGURATION INSTEAD OF THE CURRENT CONFIGURATION, 2)CHANGING THE LOCATION OF THE SKINT TEST PACKAGING OPERATIN FROM COLLAGEN CORP, FREMONT, CA, TO BARD UROLOGICAL DIV, COVINGTON, GA 3)REVISING THE WARNING STATEMENT REGARDING CONNECTIVE TISSUE DISEASE IN THE PACKAGE INSERTS, PATIENT BROCHURES AND SAFETY SUMMARIES, AND 4)UPDATING THE PATIENT RECORD AND SKIN TEST CARD LABELING

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
REFRESH RELIEVA For CONTACTS (K190674)Allergan, Inc.2019-08-08
XEN Glaucoma Treatment System (K161457)Allergan, Inc.2016-11-21
Natrelle 133 Plus Tissue Expander (K143354)Allergan, Inc.2015-08-20
REFRESH OPTIVE LENS COMFORT REWETTING DROPS (K083812)Allergan, Inc.2009-07-09
SINGLE AMPLIFIER FOR BOTOX (K051852)Allergan, Inc.2005-09-14
COMPLETE BRAND MULTI-PURPOSE SOLUTION (K014202)Allergan, Inc.2002-02-20
COMPLETE BRAND MULTI-PURPOSE SOLUTION (K013479)Allergan, Inc.2002-02-11
COMPLETE BRAND MULTI-PURPOSE SOLUTION (K003252)Allergan, Inc.2001-02-21